Cellectis SA (CLLS)
2.99
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
3.05
+0.06
(+2.01%)
After-Hours: 20:00
Cellectis Price: 2.99 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.89 | 3.09 | 2.89 | 2.99 | 90809.00 |
May 02, 2024 | 2.70 | 3.010 | 2.641 | 2.99 | 299774.0 |
May 01, 2024 | 2.593 | 2.60 | 2.53 | 2.536 | 3856.00 |
Apr 30, 2024 | 2.52 | 2.56 | 2.500 | 2.56 | 9080.00 |
Apr 29, 2024 | 2.37 | 2.611 | 2.37 | 2.56 | 22427.00 |
Apr 26, 2024 | 2.490 | 2.506 | 2.35 | 2.506 | 223279.0 |
Apr 25, 2024 | 2.47 | 2.614 | 2.47 | 2.49 | 14710.00 |
Apr 24, 2024 | 2.53 | 2.570 | 2.48 | 2.50 | 39301.00 |
Apr 23, 2024 | 2.46 | 2.650 | 2.46 | 2.620 | 47230.00 |
Apr 22, 2024 | 2.59 | 2.65 | 2.59 | 2.64 | 23573.00 |
Apr 19, 2024 | 2.58 | 2.58 | 2.510 | 2.55 | 11743.00 |
Apr 18, 2024 | 2.53 | 2.63 | 2.30 | 2.47 | 14990.00 |
Apr 17, 2024 | 2.57 | 2.61 | 2.451 | 2.46 | 6942.00 |
Apr 16, 2024 | 2.50 | 2.65 | 2.485 | 2.49 | 84326.00 |
Apr 15, 2024 | 2.59 | 2.65 | 2.53 | 2.61 | 41919.00 |
Apr 12, 2024 | 2.80 | 2.80 | 2.67 | 2.69 | 60116.00 |
Apr 11, 2024 | 2.81 | 2.855 | 2.78 | 2.80 | 14726.00 |
Apr 10, 2024 | 2.66 | 2.807 | 2.66 | 2.79 | 11928.00 |
Apr 09, 2024 | 2.82 | 2.82 | 2.70 | 2.75 | 20196.00 |
Apr 08, 2024 | 2.69 | 2.89 | 2.60 | 2.69 | 82017.00 |
Apr 05, 2024 | 2.700 | 2.740 | 2.66 | 2.68 | 13274.00 |
Apr 04, 2024 | 2.755 | 2.886 | 2.72 | 2.75 | 21287.00 |
Apr 03, 2024 | 2.80 | 2.95 | 2.66 | 2.79 | 46117.00 |
Apr 02, 2024 | 2.66 | 2.69 | 2.56 | 2.65 | 36851.00 |
Apr 01, 2024 | 2.61 | 2.64 | 2.41 | 2.54 | 42508.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.97
Minimum
Oct 31 2023
33.25
Maximum
Jan 19 2021
9.994
Average
9.09
Median
Mar 17 2020
Price Benchmarks
Biophytis SA | 8.95 |
DBV Technologies SA | 0.6669 |
Genfit SA | 3.66 |
Edap TMS SA | 7.14 |
Adaptimmune Therapeutics PLC | 1.19 |
Price Related Metrics
PS Ratio | 225.87 |
Price to Book Value | 2.540 |
Earnings Yield | -59.53% |
Market Cap | 215.14M |